TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ANVS

Annovis Bio Inc

Healthcare · Biotechnology

1.30$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Ownership

Ownership Structure

Who owns Annovis Bio Inc (ANVS)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 82.8% of the shares are freely tradable; institutional investors hold 24.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 24.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 8.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 82.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 12.9%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 43Mio.

Largest Shareholders

Institutions

Institutions ANVS
Name Stake (%) Shares Change (%) Date
Empery Asset Management, LP 5.64 2,401,476 +0.0 06/30/2026
Tudor Investment Corp Et AL 3.19 1,357,134 +0.0 06/30/2026
Marshall Wace Asset Management Ltd 2.79 1,187,499 +63.6 03/31/2026
Vanguard Capital Management, LLC 2.05 872,381 +0.0 03/31/2026
Two Sigma Investments LLC 1.36 579,571 -7.7 06/30/2026
Renaissance Technologies Corp 0.82 347,600 +0.0 03/31/2026
Geode Capital Management, LLC 0.58 247,513 +11.4 03/31/2026
Citadel Advisors Llc 0.57 243,682 +0.0 06/30/2026

Funds

Funds ANVS
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 4.48 1,219,718 +0.0 08/31/2026
Fidelity Extended Market Index 0.56 153,136 -0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?